Calvin J. Ice, PharmD, BCPS, BCCCP, FASHP (calvin.ice@corewellhealth.org) is a clinical pharmacy manager of training and education at Corewell Health in Grand Rapids, MI. He obtained his PharmD at Ohio Northern University and completed a PGY1 pharmacy residency followed by a PGY2 critical care pharmacy residency at Mayo Clinic in Rochester, MN. He spent three years as a surgical ICU clinical pharmacy specialist at Spectrum Health before transitioning to a clinical pharmacy supervisor role in 2018. As a supervisor, he led departmental initiatives on clinical workflows and oversaw pharmacy intern, longitudinal student, and resident teams at Corewell Health Grand Rapids Hospitals (formerly Spectrum Health). He is currently a PGY1 residency program director at Corewell Health and serves as an adjunct assistant professor for Ferris State University. Dr. Ice continues to practice in the surgical ICU and now leads pharmacy trainee teams throughout the Corewell Health system.
Dr. Ice is member of ASHP since 2010 and has served in appointed roles within the Pharmacy Student Forum as an advisory group chair; New Practitioners Forum as an advisory group chair, Executive Committee vice chair and chair, and delegate to the ASHP House of Delegates; Section of Clinical Specialists and Scientists member of the Clinical Leadership Advisory Group; and member of the Council on Therapeutics. As a member of the Clinical Leadership Advisory Group since 2018, Dr. Ice has worked with several teams to develop multiple resources, webinars, podcasts, and programming proposals to educate ASHP members as a workgroup lead, secretary, and vice chair.
We as clinical pharmacy specialists and scientists are faced with numerous unique challenges in advancing pharmacy practice; however, our goal with any of these challenges remains the same in providing the right drug to the right patient at the right time. In our dynamic healthcare landscape, we are also challenged to innovate both within our therapeutic approaches and also within our practice models. Our section is well-positioned in providing guidance and resources in facing these challenges and can continue to support our members with access to resources, programming, webinars, and podcasts tailored to keep our members prepared as experts to provide our patients with the highest quality clinical care in the face of novel therapies and evolving practices.
It is an honor to be nominated to serve as chair of the section, and I am excited for the opportunity to continue to serve the section’s mission to collaborate, educate, and innovate to advance pharmacy practice and optimize outcomes for patients of all backgrounds. If elected as chair, I look forward to the opportunity to use the skills in collaboration and leadership I have developed as an ASHP leader the past 15 years as a student, new practitioner, and now more experienced practitioner. I am excited to collaborate with our section members and leaders on a shared vision to integrate our scientific advances and knowledge into practice and improved patient outcomes while highlighting the value each of us brings to our patients.